Novel pyridyl-fused 3-amino chroman derivatives with dual action at serotonin transporter and 5-HT1A receptor

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 11, 2007, Pages 3117-3121

  Zhou, Dahui ^a   Hatzenbuhler, Nicole T ^a   Gross, Jonathan L ^a   Harrison, Boyd L ^a   Evrard, Deborah A ^a   Chlenov, Michael ^a   Golembieski, Jeannette ^a   Hornby, Geoffrey ^a   Schechter, Lee E ^a   Smith, Deborah L ^a   Andree, Terrance H ^a   Stack, Gary P ^a  

^a PFIZER INC   (United States)

Author keywords

5 HT1A receptor; Serotonin transporter

Indexed keywords

3 AMINOCHROMAN; CHROMAN DERIVATIVE; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DRUG BINDING; DRUG IDENTIFICATION; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; NONHUMAN; RAT;

ANIMALS; CHROMANS; HUMANS; RATS; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS;

EID: 34247855969     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.03.049     Document Type: Article

References (20)

1. Blier P., and Bergeron R. J. Clin. Psychiatry 59 (1998) 16
2. Kreiss D.S., and Lucki I. J. Pharmacol. Exp. Ther. 274 (1995) 219
3. Artigas F., Perez V., and Alvarez E. Arch. Gen. Psychiatry 51 (1994) 248
4. Blier P., and Bergeron R. J. Clin. Psychopharm. 15 (1995) 217
5. Mewshaw R.E., Zhou D., Zhou P., Shi X., Hornby G., Spangler T., Scerni R., Smith D., Schechter L.E., and Andree T.H. J. Med. Chem. 47 (2004) 3823
6. Martinez-Esparza J., Oficialdegui A.M., Perez-Silanes S., Heras B., Orus L., Palop J.A., Lasheras B., Roca J., Mourelle M., Bosch A., Del Castillo J.C., Tordera R., Del Rio J., and Monge A. J. Med. Chem. 44 (2001) 418
7. Takeuchi K., Kohn T.J., Honigschmidt N.A., Rocco V.P., Spinazze P.G., Koch D.J., Atkinsion S.T., Hertel L.W., Nelson D.L., Wainscott D.B., Ahmad L.J., Shaw J., Threlkeld P.G., and Wong D.T. Bioorg. Med. Chem. Lett. 13 (2003) 2393
8. Atkinson P.J., Bromidge S.M., Duxon M.S., Gaster L.M., Hadley M.S., Hammond B., Johnson C.N., Middlemiss D.N., North S.E., Price G.W., Rami H.K., Riley G.J., Scott C.M., Shaw T.E., Starr K.R., Stemp G., Thewlis K.M., Thomas D.R., Thompson M., Vong A.K.K., and Watson J.M. Bioorg. Med. Chem. Lett. 15 (2005) 737
9. Page M.E., Cryan J.F., Sullivan A., Dalvi A., Saucy B., Manning D.R., and Lucki I. J. Pharmacol. Exp. Ther. 302 (2002) 1220
10. Podona T., Guardiola-Lemaitre B., Caignard D.H., Adam G., Pfeiffer B., Renard P., and Guillaumet G. J. Med. Chem. 37 (1994) 1779
11. Hatzenbuhler N.T., Evrard D.A., Harrison B.L., Inghrim J., Mewshaw R.E., Zhou D., Beyer C.E., Hornby G., Smith D.L., Sullivan K.M., Lin Q., Schechter L.E., and Andree T.H. J. Med. Chem. 49 (2006) 4785
12. Tran, M.; Stack, G. P. U.S. Patent 6,458,802, 2002.
13. Trump-Kallmeyer S., Hoflack J., Bruinvels A., and Hibert M. J. Med. Chem. 35 (1992) 3448
14. Kolb H.C., VanNieuwenhze M.S., and Sharpless K.B. Chem. Rev. 94 (1994) 2483
15. Lopez-Rodriguez M., Morcillo M.J., Fernandez E., Benhamu B., Tejada I., Ayala D., Viso A., Campillo M., Pardo L., Delgado M., Manzanares J., and Fuentes J.A. J. Med. Chem. 48 (2005) 2548
16. Cheng Y.-C., and Prusoff W.H. Biochem. Pharmacol. 23 (1973) 3099
17. Cheetham S.C., Viggers J.A., Slater N.A., Heal D.J., and Buckett W.R. Neuropharmacology 32 (1993) 737
18. Dunlop J., Zhang Y., Smith D.L., and Schechter L.E. J. Pharmacol. Toxicol. Methods 40 (1998) 47
19. Morrow A., and Creese I. Mol. Pharmacol. 29 (1986) 32117
20. Lazareno S., and Birdsall N.J. Br. J. Pharmacol. 109 (1993) 1120